Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Added to Russell 1000 and Russell 3000 Indexes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that its common stock has been added to the US large-cap Russell 1000 Index and the broad market Russell 3000 Index.

Russell Investments reconstituted its equity indexes after the close of the market on Friday, resulting in Qiagen's inclusion, the molecular diagnostics and sample prep technologies firm said.

The Russell 3000 Index measures the performance of the 3,000 largest companies in the US and represents roughly 90 percent of the investible US equity market. The Russell 1000 Index represents the highest-ranking 1,000 companies in the US.

"This inclusion provides further support and liquidity for Qiagen's common shares, and thereby more benefits to participating in Qiagen's growth and creation of value for shareholders,” Qiagen CEO Peer Schatz said in a statement.

In early afternoon trading today on Nasdaq, shares of Qiagen were up 1 percent at $18.89.

Filed under

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.